chinese glp 1 China approves first home-grown GLP-1 weight loss drug, rivaling Ozempic | Yanzhong Huang posted on the topic Rival GLP-1 Weight-Loss Drug Emerges

10.3389/fendo.2023.1244432 131 XuG.StoffersD

Scenario 1: Menopausal woman starting both therapies You are 52, postmenopausal, experiencing hot flashes, sleep disruption, and a 30-pound weight gain concentrated around your midsection

So far most of the trials in this area have been small and led by academic investigators

Ali Larter, 49 Feeling confident enough to strip down to a bikini on Landman starts with discipline

Consistent with the RCTs, a metaanalysis did not show an increased risk of pancreatitis among users of GLP1 analogues (OR 0.93, CI 0.651.34) [19]

The risk of yo-yo effects, where patients lose muscle on the drug and regain fat after stopping, is a real concern